Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01314040
Other study ID # A1003/ WP-B1
Secondary ID
Status Completed
Phase N/A
First received February 25, 2011
Last updated May 30, 2011
Start date March 2011
Est. completion date April 2011

Study information

Verified date May 2011
Source Wageningen University
Contact n/a
Is FDA regulated No
Health authority Netherlands: Medical Ethics Review Committee (METC)
Study type Interventional

Clinical Trial Summary

Results from observational studies suggest a small beneficial association between protein and blood pressure that may be mainly attributable to the intake of protein from plant sources. In epidemiological studies biomarkers of dietary intake are useful to estimate intake more reliably. Dietary studies using biomarkers of protein intake generally show stronger associations with health outcomes. However, data on biomarkers for specific types of protein (e.g. from dairy, meat, grain and legumes) are scarce. Therefore the purpose of this study is to identify new biomarkers for the intake of protein from meat, dairy and grain. In addition the secondary purpose is to investigate whether intake of protein from these sources influences kidney filtration rate and urinary acid excretion differentially.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date April 2011
Est. primary completion date April 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Age 18-40 years

- BMI between 18.5 and 30 kg/m2

- Healthy (As judged by the participant)

- Written informed consent obtained

Exclusion Criteria:

- Unable or unwilling to comply with study procedures.

- Unusual dietary patterns, including high alcohol intakes (= 2 glasses/day) and a vegetarian diet

- Recent (< 4 weeks) or current participation in a study with any investigational drug or dietary intervention

- Usage of an energy restricted diet during the last two months

- Weight loss or weight gain of 5 kg or more during the last two months

- Smoking

- Stomach or bowel diseases

- Kidney disorders

- Diabetes, thyroid disease, other endocrine disorders

- Prevalent cardiovascular disease

- Extreme sports (>8h/ wk)

- Usage of any prescribed medication except for oral contraceptives

- Use of systemic antibiotics in the period of 3 month prior to the study

- For women: pregnant or lactating

- For women: not using oral contraceptives

- For women: Unwilling to use oral contraceptives for consecutively for at least the total study duration

- Liver function parameters (ALAT, ASAT, and ?-GT) and renal function parameters (Serum creatinin) outside the normal range

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label


Related Conditions & MeSH terms

  • Identify New Biomarkers in Blood or Urine After Consumption of Meat Protein, Dairy Protein and Grain Protein in Healthy Subjects.

Intervention

Other:
Run in diet
Fully controlled dietary period during 9 days. Participants will receive approximately 15 en% of protein. The amount of protein intake from dairy, meat, and grain will be equal to each other
High meat protein diet
Fully controlled diet during 7 days. Participants will consume 18 en% protein, mainly from meat.
High dairy protein diet
Fully controlled dietary intervention during 7 days. Participants will consume 20 en% protein. Mainly from dairy
High grain protein diet
Fully controlled dietary intervention for 7 days. Participants will consume 20 en% of protein. Mainly from grain

Locations

Country Name City State
Netherlands Wageningen University Wageningen Gelderland

Sponsors (2)

Lead Sponsor Collaborator
Wageningen University Top Institute Food and Nutrition

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Differences between dietary periods in concentrations of potential biomerkers in blood and urine Potential biomarkers that will be measured are urinary creatinin, sulphate, carnosine, 1-MH, 3-MH, taurine,14N/15N and creatin in blood. Furthermore, amino acid profiling will be done in blood and urine to detect differences between dietary periods On the last day of every one week intervention period No
Secondary Differences between dietary period in estimated renal filtration Renal filtration will be estimated using bromide distribution in combination with bio-impedance measurement blood and urine collection on the last day of each intervention period No
Secondary Differences between dietary periods in urinary acid excretion urine collection on the last day of each intervention period No